Efficacy and Safety of Dapagliflozin-Vildagliptin in Indian T2DM Patients with CV Risk Factors Dr. Bhumika Maikhuri30 Jan 2026 12:58 PM ISTThe Fixed-Dose Combination (FDC) of Dapagliflozin 5 mg + Vildagliptin 50 mg demonstrated significant improvements in Glycemic Control, Metabolic...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
Higher Uric Acid at Diagnosis Linked to Complications in Young T1DM Patients: Study Jacinthlyn Sylvia24 Jan 2026 10:45 AM ISTA new study published in the journal of Diabetologia showed that both macrovascular and microvascular problems in later life may be associated with...
Diabetes Linked to Higher Male Infertility Risk, Stronger in Type 2 Diabetes: Meta-Analysis Shows Medha Baranwal21 Jan 2026 9:15 AM ISTChina: A review published in Frontiers in Endocrinology reports an increased risk of infertility among men with diabetes, with the association being...
Zydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes Susmita Roy9 Jan 2026 11:45 PM ISTNew Delhi: Drug major Zydus Lifesciences Limited has received a key regulatory clearance from the Subject Expert Committee (SEC) functioning under the...
Ketogenic Diet Plus Dulaglutide Enhances Metabolic Control in Diabetes: Study Shows Medha Baranwal3 Dec 2025 9:15 AM ISTChina: A new study from China suggests that integrating a ketogenic diet with dulaglutide therapy may offer superior improvements in glucose and lipid...
Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes Susmita Roy2 Dec 2025 10:22 PM ISTNew Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
Is Low-Carbohydrate Diet Safe and Effective for Type 2 Diabetes Remission in Long-Term? Dr. Bhumika Maikhuri24 Oct 2025 11:16 AM ISTA recent systematic review has found that low-carbohydrate diets (LCDs) and ketogenic diets (KDs) are effective and viable strategies for achieving...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
CDSCO Panel Seeks More Clinical Data from Regenix Drugs on rDNA-Based Insulin Injection Susmita Roy16 Oct 2025 7:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has asked Regenix Drugs Ltd...
EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress Deeksha Bhandari14 Oct 2025 12:51 PM ISTEvery 12 minutes, a person with diabetes thinks about their condition. For many, this constant burden leads to diabetes distress-a state of...
Diabetes Increases Risk of Oral and Maxillofacial Diseases: Study Dr Riya Dave15 Sept 2025 9:15 PM ISTAn analysis of 6,868 patients published in the Dentistry Journal has revealed that individuals with diabetes face higher risks of malignant tumors,...
